Acucela Strikes Third Ophthalmology Deal With Otsuka For Glaucoma Drug
This article was originally published in PharmAsia News
Executive Summary
Seattle-based ophthalmology specialist Acucela has struck its third partnership with Japanese pharma Otsuka Pharmaceutical Co., this time to collaborate on development of a preclinical glaucoma treatment